CD8A and leukemia: Identification of immunogenic WT1 epitopes, capable of eliciting an anti-leukemia cytotoxic CD8+ T cells was reported in 2000 (158), thus providing the rationale and preclinical background for the development of clinical studies using WT1 vaccines.